Coactivation of GABAA and GABAB Receptor Results in Neuroprotection during In Vitro Ischemia

Cinzia Costa, Giorgia Leone, Emilia Saulle, Francesco Pisani, Giorgio Bernardi, Paolo Calabresi

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Background and Purpose - The possible neuroprotective effect of endogenous γ-aminobutyric acid (GABA) on the irreversible electrophysiological changes induced by in vitro ischemia on striatal neurons was investigated. In particular, the aim of the study was the characterization of the neuroprotective action of 2 antiepileptic drugs increasing GABAergic transmission such as tiagabine, a GABA transporter inhibitor, and vigabatrin, an irreversible inhibitor of GABA transaminase. Methods - Extracellular field potential recordings were obtained from rat corticostriatal slice preparations . In vitro ischemia was delivered by switching to an artificial cerebrospinal fluid solution in which glucose was omitted and oxygen was replaced with N 2. Results - An irreversible loss of the field potentials recorded from striatal neurons was observed after 10 minutes of ischemia in control solution. Conversely, tiagabine and vigabatrin partially prevented the ischemia-induced field potential loss. Surprisingly, both GABAA and GABAB receptor antagonists blocked these effects. Accordingly, neuroprotection could be obtained only when GABAA and GABA B receptor agonists were coapplied, but not when a single agonist was given in isolation. Conclusions - Antiepileptic drugs targeting GABAergic transmission can exert neuroprotective effects against ischemia by increasing endogenous GABA levels and via the activation of both GABAA and GABAB receptors.

Original languageEnglish
Pages (from-to)596-600
Number of pages5
JournalStroke
Volume35
Issue number2
DOIs
Publication statusPublished - Feb 2004

Fingerprint

GABA-A Receptors
Ischemia
Vigabatrin
Corpus Striatum
Neuroprotective Agents
Anticonvulsants
gamma-Aminobutyric Acid
GABA-B Receptor Agonists
GABA Plasma Membrane Transport Proteins
4-Aminobutyrate Transaminase
Aminobutyrates
GABA-A Receptor Antagonists
Neurons
Drug Delivery Systems
Cerebrospinal Fluid
In Vitro Techniques
Neuroprotection
Oxygen
Glucose
tiagabine

Keywords

  • Anticonvulsants
  • Corpus striatum
  • Electrophysiology
  • GABA
  • Ischemia
  • Receptors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Coactivation of GABAA and GABAB Receptor Results in Neuroprotection during In Vitro Ischemia. / Costa, Cinzia; Leone, Giorgia; Saulle, Emilia; Pisani, Francesco; Bernardi, Giorgio; Calabresi, Paolo.

In: Stroke, Vol. 35, No. 2, 02.2004, p. 596-600.

Research output: Contribution to journalArticle

Costa, Cinzia ; Leone, Giorgia ; Saulle, Emilia ; Pisani, Francesco ; Bernardi, Giorgio ; Calabresi, Paolo. / Coactivation of GABAA and GABAB Receptor Results in Neuroprotection during In Vitro Ischemia. In: Stroke. 2004 ; Vol. 35, No. 2. pp. 596-600.
@article{098fea4e167041ea9a6d3a1b5092a7e1,
title = "Coactivation of GABAA and GABAB Receptor Results in Neuroprotection during In Vitro Ischemia",
abstract = "Background and Purpose - The possible neuroprotective effect of endogenous γ-aminobutyric acid (GABA) on the irreversible electrophysiological changes induced by in vitro ischemia on striatal neurons was investigated. In particular, the aim of the study was the characterization of the neuroprotective action of 2 antiepileptic drugs increasing GABAergic transmission such as tiagabine, a GABA transporter inhibitor, and vigabatrin, an irreversible inhibitor of GABA transaminase. Methods - Extracellular field potential recordings were obtained from rat corticostriatal slice preparations . In vitro ischemia was delivered by switching to an artificial cerebrospinal fluid solution in which glucose was omitted and oxygen was replaced with N 2. Results - An irreversible loss of the field potentials recorded from striatal neurons was observed after 10 minutes of ischemia in control solution. Conversely, tiagabine and vigabatrin partially prevented the ischemia-induced field potential loss. Surprisingly, both GABAA and GABAB receptor antagonists blocked these effects. Accordingly, neuroprotection could be obtained only when GABAA and GABA B receptor agonists were coapplied, but not when a single agonist was given in isolation. Conclusions - Antiepileptic drugs targeting GABAergic transmission can exert neuroprotective effects against ischemia by increasing endogenous GABA levels and via the activation of both GABAA and GABAB receptors.",
keywords = "Anticonvulsants, Corpus striatum, Electrophysiology, GABA, Ischemia, Receptors",
author = "Cinzia Costa and Giorgia Leone and Emilia Saulle and Francesco Pisani and Giorgio Bernardi and Paolo Calabresi",
year = "2004",
month = "2",
doi = "10.1161/01.STR.0000113691.32026.06",
language = "English",
volume = "35",
pages = "596--600",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Coactivation of GABAA and GABAB Receptor Results in Neuroprotection during In Vitro Ischemia

AU - Costa, Cinzia

AU - Leone, Giorgia

AU - Saulle, Emilia

AU - Pisani, Francesco

AU - Bernardi, Giorgio

AU - Calabresi, Paolo

PY - 2004/2

Y1 - 2004/2

N2 - Background and Purpose - The possible neuroprotective effect of endogenous γ-aminobutyric acid (GABA) on the irreversible electrophysiological changes induced by in vitro ischemia on striatal neurons was investigated. In particular, the aim of the study was the characterization of the neuroprotective action of 2 antiepileptic drugs increasing GABAergic transmission such as tiagabine, a GABA transporter inhibitor, and vigabatrin, an irreversible inhibitor of GABA transaminase. Methods - Extracellular field potential recordings were obtained from rat corticostriatal slice preparations . In vitro ischemia was delivered by switching to an artificial cerebrospinal fluid solution in which glucose was omitted and oxygen was replaced with N 2. Results - An irreversible loss of the field potentials recorded from striatal neurons was observed after 10 minutes of ischemia in control solution. Conversely, tiagabine and vigabatrin partially prevented the ischemia-induced field potential loss. Surprisingly, both GABAA and GABAB receptor antagonists blocked these effects. Accordingly, neuroprotection could be obtained only when GABAA and GABA B receptor agonists were coapplied, but not when a single agonist was given in isolation. Conclusions - Antiepileptic drugs targeting GABAergic transmission can exert neuroprotective effects against ischemia by increasing endogenous GABA levels and via the activation of both GABAA and GABAB receptors.

AB - Background and Purpose - The possible neuroprotective effect of endogenous γ-aminobutyric acid (GABA) on the irreversible electrophysiological changes induced by in vitro ischemia on striatal neurons was investigated. In particular, the aim of the study was the characterization of the neuroprotective action of 2 antiepileptic drugs increasing GABAergic transmission such as tiagabine, a GABA transporter inhibitor, and vigabatrin, an irreversible inhibitor of GABA transaminase. Methods - Extracellular field potential recordings were obtained from rat corticostriatal slice preparations . In vitro ischemia was delivered by switching to an artificial cerebrospinal fluid solution in which glucose was omitted and oxygen was replaced with N 2. Results - An irreversible loss of the field potentials recorded from striatal neurons was observed after 10 minutes of ischemia in control solution. Conversely, tiagabine and vigabatrin partially prevented the ischemia-induced field potential loss. Surprisingly, both GABAA and GABAB receptor antagonists blocked these effects. Accordingly, neuroprotection could be obtained only when GABAA and GABA B receptor agonists were coapplied, but not when a single agonist was given in isolation. Conclusions - Antiepileptic drugs targeting GABAergic transmission can exert neuroprotective effects against ischemia by increasing endogenous GABA levels and via the activation of both GABAA and GABAB receptors.

KW - Anticonvulsants

KW - Corpus striatum

KW - Electrophysiology

KW - GABA

KW - Ischemia

KW - Receptors

UR - http://www.scopus.com/inward/record.url?scp=0842289182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842289182&partnerID=8YFLogxK

U2 - 10.1161/01.STR.0000113691.32026.06

DO - 10.1161/01.STR.0000113691.32026.06

M3 - Article

C2 - 14726544

AN - SCOPUS:0842289182

VL - 35

SP - 596

EP - 600

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 2

ER -